SCHEMBL20306282

SCHEMBL20306282

CC(C)(C)Cc1ccc2c(c1)OCCNC2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 1/20 0.47
GSK3B P49841 1/20 0.42
PARP11 Q9NR21 2/20 0.35
GRM5 P41594 1/20 0.35
ALPL P05186 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PARP10 Q53GL7 1/20 0.34
MAOB P27338 1/20 0.34
NTRK1 P04629 6/20 0.34
JAK2 O60674 5/20 0.34
JAK1 P23458 2/20 0.34
JAK3 P52333 2/20 0.34
ALK Q9UM73 2/20 0.34
ROS1 P08922 1/20 0.34
MAPKAPK2 P49137 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MKNK1 Q9BUB5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594591 0.80 ALDH1A1 (0.45) FABP6GRM5ALDH1A1GAAMAPT
SCHEMBL701202 0.78 FABP6 (0.50) FABP6GSK3BPARP11ALPLALDH1A1
SCHEMBL22210654 0.77 ALDH1A1 (0.57) FABP6GRM5ALDH1A1GAAMAPT
SCHEMBL2061574 0.76 FABP6 (0.54) FABP6GSK3BPARP11ALDH1A1GAA
SCHEMBL10274616 0.76 ALDH1A1 (0.56) FABP6GSK3BPARP11GRM5ALDH1A1
SCHEMBL15586859 0.76 FABP6 (0.48) FABP6GSK3BPARP11ALPLALDH1A1
SCHEMBL19386434 0.75 PARP11 (0.61) PARP11GRM5PARP10
SCHEMBL16014463 0.75 FABP6 (0.47) FABP6GSK3BPARP11ALPLALDH1A1
SCHEMBL29731708 0.75 PRMT5 (0.49) FABP6GSK3BALDH1A1GAA
SCHEMBL2994247 0.73 MAOA (0.58) FABP6GSK3BALDH1A1MAPTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005774-B2 Syk inhibitors GILEAD SCIENCES, INC. (US) 2018-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005774-B2 Syk inhibitors SYK, BTK, LYN FABP6 4824/4885GSK3B 209/4885PARP11 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.